Investigating the Effect of Reirradiation or Systemic Therapy in Patients With Glioblastoma After Tumor Progression: A Secondary Analysis of NRG Oncology/Radiation Therapy Oncology Group Trial 0525 Article

Shi, Wenyin, Bryan, Molly Scannell, Gilbert, Mark R et al. (2018). Investigating the Effect of Reirradiation or Systemic Therapy in Patients With Glioblastoma After Tumor Progression: A Secondary Analysis of NRG Oncology/Radiation Therapy Oncology Group Trial 0525 . INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 100(1), 38-44. 10.1016/j.ijrobp.2017.08.038

Open Access International Collaboration

cited authors

  • Shi, Wenyin; Bryan, Molly Scannell; Gilbert, Mark R; Mehta, Minesh P; Blumenthal, Deborah T; Brown, Paul D; Valeinis, Egils; Hopkins, Kirsten; Souhami, Luis; Andrews, David W; Tzuk-Shina, Tzahala; Howard, Steve P; Youssef, Emad F; Lessard, Nathalie; Dignam, James J; Werner-Wasik, Maria

sustainable development goals

authors

publication date

  • January 1, 2018

webpage

published in

keywords

  • BCNU
  • BEVACIZUMAB PLUS IRINOTECAN
  • EFFICACY
  • HIGH-GRADE GLIOMA
  • Life Sciences & Biomedicine
  • MULTIFORME
  • Oncology
  • PHASE-II TRIAL
  • RECURRENT MALIGNANT GLIOMAS
  • Radiology, Nuclear Medicine & Medical Imaging
  • STEREOTACTIC RADIOSURGERY
  • Science & Technology
  • TEMOZOLOMIDE

Digital Object Identifier (DOI)

publisher

  • ELSEVIER SCIENCE INC

start page

  • 38

end page

  • 44

volume

  • 100

issue

  • 1